Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors
In neuroendocrine tumors molecular imaging methods play a key role, either targeting the somatostatin receptor or catecholamine pathways. [18F]SiTATE is a somatostatin receptor-targeting peptide that uses silicon fluoride acceptor (SiFA) radiochemistry, overcoming disadvantages of Gallium-68 labelle...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2025
|
| In: |
European journal of nuclear medicine and molecular imaging
|
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-025-07572-w |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-025-07572-w |
| Author Notes: | Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1939720192 | ||
| 003 | DE-627 | ||
| 005 | 20251030075929.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251030s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-025-07572-w |2 doi | |
| 035 | |a (DE-627)1939720192 | ||
| 035 | |a (DE-599)KXP1939720192 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Roll, Wolfgang |d 1988- |e VerfasserIn |0 (DE-588)112590514X |0 (DE-627)880471840 |0 (DE-576)483614823 |4 aut | |
| 245 | 1 | 0 | |a Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors |c Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis |
| 264 | 1 | |c 2025 | |
| 300 | |b Illustrationen, Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist "18F" in eckigen Klammern geschrieben und hochgestellt | ||
| 500 | |a Online veröffentlicht: 26. September 2025 | ||
| 500 | |a Gesehen am 30.10.2025 | ||
| 520 | |a In neuroendocrine tumors molecular imaging methods play a key role, either targeting the somatostatin receptor or catecholamine pathways. [18F]SiTATE is a somatostatin receptor-targeting peptide that uses silicon fluoride acceptor (SiFA) radiochemistry, overcoming disadvantages of Gallium-68 labelled DOTA compounds. Here we present the first prospective data of [18F]SiTATE compared to [18F]DOPA-PET in NET patients. | ||
| 650 | 4 | |a [18F]DOPA | |
| 650 | 4 | |a [18F]SiTATE | |
| 650 | 4 | |a Neuroendocrine tumor | |
| 700 | 1 | |a Hadjitheodorou, Panayiotis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alevroudis, Emmanouil |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kyrou, Kyriaki |e VerfasserIn |4 aut | |
| 700 | 1 | |a Adamou, Giorgos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fesas, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wängler, Björn |d 1975- |e VerfasserIn |0 (DE-588)129702218 |0 (DE-627)477593909 |0 (DE-576)297793888 |4 aut | |
| 700 | 1 | |a Wängler, Carmen |d 1978- |e VerfasserIn |0 (DE-588)133775593 |0 (DE-627)556368177 |0 (DE-576)30009230X |4 aut | |
| 700 | 1 | |a Schirrmacher, Ralf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pourkhessalian, Mohammad R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kalogirou, Charalambia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tsechelidis, Ioannis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vrachimis, Alexis |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g (2025) |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors |
| 773 | 1 | 8 | |g year:2025 |g extent:8 |a Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00259-025-07572-w |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251030 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 133775593 |a Wängler, Carmen |m 133775593:Wängler, Carmen |d 60000 |d 62900 |d 60000 |e 60000PW133775593 |e 62900PW133775593 |e 60000PW133775593 |k 0/60000/ |k 1/60000/62900/ |k 0/60000/ |p 8 | ||
| 998 | |g 129702218 |a Wängler, Björn |m 129702218:Wängler, Björn |d 60000 |d 62900 |e 60000PW129702218 |e 62900PW129702218 |k 0/60000/ |k 1/60000/62900/ |p 7 | ||
| 999 | |a KXP-PPN1939720192 |e 4794550111 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors","title_sort":"Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors"}],"name":{"displayForm":["Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis"]},"person":[{"role":"aut","given":"Wolfgang","display":"Roll, Wolfgang","family":"Roll"},{"role":"aut","given":"Panayiotis","display":"Hadjitheodorou, Panayiotis","family":"Hadjitheodorou"},{"family":"Alevroudis","display":"Alevroudis, Emmanouil","role":"aut","given":"Emmanouil"},{"display":"Kyrou, Kyriaki","given":"Kyriaki","role":"aut","family":"Kyrou"},{"family":"Adamou","display":"Adamou, Giorgos","role":"aut","given":"Giorgos"},{"given":"Andreas","role":"aut","display":"Fesas, Andreas","family":"Fesas"},{"family":"Wängler","given":"Björn","role":"aut","display":"Wängler, Björn"},{"family":"Wängler","display":"Wängler, Carmen","given":"Carmen","role":"aut"},{"given":"Ralf","role":"aut","display":"Schirrmacher, Ralf","family":"Schirrmacher"},{"family":"Pourkhessalian","display":"Pourkhessalian, Mohammad R.","role":"aut","given":"Mohammad R."},{"family":"Kalogirou","display":"Kalogirou, Charalambia","given":"Charalambia","role":"aut"},{"role":"aut","given":"Ioannis","display":"Tsechelidis, Ioannis","family":"Tsechelidis"},{"display":"Vrachimis, Alexis","role":"aut","given":"Alexis","family":"Vrachimis"}],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"recId":"1939720192","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Im Titel ist \"18F\" in eckigen Klammern geschrieben und hochgestellt","Online veröffentlicht: 26. September 2025","Gesehen am 30.10.2025"],"relHost":[{"id":{"zdb":["2098375-X"],"issn":["1619-7089"],"eki":["359787258"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumorsEuropean journal of nuclear medicine and molecular imaging","note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"359787258","origin":[{"dateIssuedKey":"2002","publisher":"Springer-Verl.","dateIssuedDisp":"2002-","publisherPlace":"Heidelberg [u.a.]"}],"pubHistory":["29.2002 -"],"title":[{"title":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title_sort":"European journal of nuclear medicine and molecular imaging"}],"language":["eng"],"part":{"extent":"8","text":"(2025)","year":"2025"}}],"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen, Diagramme"}],"id":{"eki":["1939720192"],"doi":["10.1007/s00259-025-07572-w"]}} | ||
| SRT | |a ROLLWOLFGAHEADTOHEAD2025 | ||